Analogously, silencing of LRP5 in prostate cancer cells leads to a robust decrease in invasion growth and skeletal metastasis in vitro and in vivo by decreasing the expression of pro‐invasive and pro‐metastatic genes.26 This evidence concerns the gene LRP5 and Familial prostate cancer.